Betting big on the growing sentiment around pharmaceutical stocks, drugmaker Concord Biotech is gearing up for a debut on Dalal Street. The company is backed by late big bull Rakesh Jhunjhunwala's investment firm RARE Trusts, which has sparked the Street's interest in the listing.